To lead in this era, medtech companies must expand how they innovate — combining scientific rigor with human connection, ...

A quarterly dividend payment from a high-quality stock may be as close to a sure thing as an investor can find on Wall Street. Even during periods of broad market weakness, the lower a stock' ...

Admiral, Coventry Building Society and Hilton have been named some of the UK's best workplaces for women in 2025.

The global Advanced Wound Care Market, valued at US$12.48 billion in 2024 stood at US$13.37 billion in 2025 and is projected ...

Terry Smith slammed two of Denmark’s largest life sciences companies — Novo Nordisk A/S and Coloplast A/S — after they weighed on the equity fund run by the man often dubbed ‘Britain’s Warren Buffett.

Coloplast remains a leader in intimate healthcare with strong growth, innovation, and dividend support, despite recent weakness. See why CLPBY stock is a buy.

In other recent news, Coloplast A/S reported several significant developments impacting its stock ratings and future outlook. Deutsche Bank (ETR: DBKGn) downgraded Coloplast’s stock from Buy to Hold, ...

Coloplast A/S fired its chief executive officer to restore investor confidence after the medical equipment maker failed to deliver sufficient shareholder returns.

Coloplast CEO Kristian Villumsen steps down from his CEO position as of today. The Board of Directors has asked Lars Rasmussen to step in as interim CEO. As the company is entering into a new ...

Coloplast CEO Kristian Villumsen steps down from his CEO position as of today. The Board of Directors has asked Lars Rasmussen to step in as interim CEO. As the company is entering into a new strategy ...

On Monday, Deutsche Bank analysts adjusted their stance on Coloplast (CSE: COLOb) A/S (COLOB:DC) (OTC: CLPBY), downgrading the medical device company’s stock rating from Buy to Hold ...